£20.94

Follow-On Biologics: Background & Issues (Biotechnology in Agriculture Industry and Medicine)

Biotechnology

Price data last checked 45 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 46 days • 46 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 46 days • 8 price levels

Days at Price

Current Price

Price Analysis

Most common price: £20 (14 days, 30.4%)

Price range: £17 - £32

Price levels: 8 different prices over 46 days

Description

A biologic is a preparation, such as a drug or a vaccine, that is made from living organisms. A follow-on biologic, or biosimilar, is similar to the brand-name (innovator) product made by the pharmaceutical or biotechnology industry. In contrast to a biologic, most commonly used drugs are synthesised via a chemical process. Biologics often require special handling (such as refrigeration) and are usually administered to patients via injection or infused directly into the bloodstream. This book provides a brief introduction to the relevant law, the regulatory framework at the FDA, the scientific challenges for the FDA in considering the approval of follow-on biologics, and a brief description of the biologics provisions in the new healthcare reform bill signed into law under President Obama, entitled the Patient Protection and Affordable Care Act (PPACA).

Product Specifications

Format: hardcover
ASIN: 1611220769
Category: Books > Subjects > Science, Nature & Maths > Biological Sciences > Biotechnology
Domain: Amazon UK
Release Date: 01 March 2011
Listed Since: 05 November 2010

Barcode

No barcode data available

Follow-On Biologics: Background & Issues (Biotechnology in Agriculture Industry and Medicine)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Biologics and Biosimilars: Drug Discovery and Clinical Applications

Biosimilars and Interchangeable Biologics: Tactical Elements

Biosimilars: A New Generation of Biologics

Biosimilars: A New Generation of Biologics

Nonclinical Development of Novel Biologics, Biosimilars and Specialty Biologics

Biosimilars and Interchangeable Biologics: Tactical Elements

Biosimilars and Interchangeable Biologics: Strategic Elements

Biosimilar and Interchangeable Biologics: From Cell Line to Commercial Launch, Two Volume Set

ASHP Biosimilars and Biologics - Implementation and Monitoring

Progress in Medical Research: Government Programs and Key Issues (Medical Procedures, Testing and Technology)

Biopharmaceuticals: Challenges and Opportunities

Biosimilars Development Strategies: Fast to Market Approaches

Directory of Approved Biopharmaceutical Products (Pharmaceutical Science S)

Biopharmaceuticals: Biochemistry and Biotechnology

The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

Directory of Approved Biopharmaceutical Products (Pharmaceutical Science S)

Introduction to Biologic and Biosimilar Product Development and Analysis (AAPS Introductions in the Pharmaceutical Sciences)

Fundamentals of Biologicals Regulation: Vaccines and Biotechnology Medicines

Biopharmaceuticals: Biochemistry and Biotechnology

Current Applications of Pharmaceutical Biotechnology: 171 (Advances in Biochemical Engineering/Biotechnology, 171)

Propelling Innovation in New Drugs: Recommendations & Considerations (Pharmacology-Research, Safety Testing and Regulation)

Safety of Biologics Therapy: Monoclonal Antibodies, Cytokines, Fusion Proteins, Hormones, Enzymes, Coagulation Proteins, Vaccines, Botulinum Toxins

Springer - Safety of Biologics Therapy Medical Reference

The Challenge of CMC Regulatory Compliance for Biopharmaceuticals